相关实验视频

Updated: Jul 9, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

用于质母细胞瘤的向治疗的有毒弹头武装抗体

Jingjing Xi¹, Kai Liu¹, Zhaolei Peng¹

¹State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Critical reviews in oncology/hematology

|November 30, 2023

概括

单克隆抗体和抗体-药物联合体 (ADC) 显示出治疗质母细胞瘤 (GBM) 的前景. 这篇评论探讨了它们的疗效,毒性以及对抗这种侵袭性脑瘤的机制.

科学领域:

神经瘤学神经瘤学
免疫治疗是一种免疫疗法.
癌症生物学癌症生物学

背景情况:

质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
目前的治疗方法有效性有限,需要新的治疗策略.

研究的目的:

对用于质母细胞瘤治疗的裸体抗体和抗体-药物合物 (ADCs) 的临床数据进行审查.
阐明ADCs在GBM病变中的作用机制.
讨论GBM目前和潜在的ADC治疗策略.

主要方法:

从PubMed和ClinicalTrials.gov.gov.gov获得的临床数据的系统审查.
基于抗体的疗法的疗效和毒性的分析.
对针对GBM目标的ADC机制的检查.

主要成果:

针对GBM正在探索抗体和ADC,显示出临床反应的潜力.
总结了针对GBM标的各种抗体疗法的疗效和毒性数据.
在GBM病变部位的ADC作用机制得到阐明.

结论:

基于抗体的疗法,包括ADCs,是治疗质母细胞瘤的一个有希望的途径.
对ADC机制和治疗策略的进一步研究对于改善患者结果至关重要.
ADCs为这种毁灭性疾病提供了新的药物选择.

关键词:

抗体与药物的结合物.临床数据临床数据质母细胞瘤 (glioblastoma) 是一个潜在的战略可能.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.